Biodesix
BDSX
About: Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Employees: 273
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
12.27% less ownership
Funds ownership: 36.57% [Q1] → 24.3% (-12.27%) [Q2]
32% less funds holding
Funds holding: 60 [Q1] → 41 (-19) [Q2]
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
70% less capital invested
Capital invested by funds: $33.4M [Q1] → $10M (-$23.3M) [Q2]
76% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 25
100% less funds holding in top 10
Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]
Financial journalist opinion
Based on 3 articles about BDSX published over the past 30 days
